Pfizer and the Challenges of the Global Pharmaceutical Industry 2019 - B

Renate Kratochvil, Phillip Christopher Nell

Research output: Other contributionEducation

Abstract

Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.Learning Objective:After working through the assignment questions for Case B, students will be able to do the following:Analyze how pharmaceutical companies strategically respond to changes in the industry.Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.Identify, analyze, and evaluate relevant data and information.
Original languageEnglish
Publication date2019
Place of PublicationOntario
PublisherIvey Publishing
Number of pages17
Publication statusPublished - 2019

Bibliographical note

CASE - Reference no. 9B19M077

Keywords

  • Industry analysis
  • Structured analysis
  • Data management
  • Multinational corporations

Cite this

@misc{c4af10f3cd374dde850a2c145a5ae288,
title = "Pfizer and the Challenges of the Global Pharmaceutical Industry 2019 - B",
abstract = "Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.Learning Objective:After working through the assignment questions for Case B, students will be able to do the following:Analyze how pharmaceutical companies strategically respond to changes in the industry.Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.Identify, analyze, and evaluate relevant data and information.",
keywords = "Industry analysis, Structured analysis, Data management, Multinational corporations, Industry analysis, Structured analysis, Data management, Multinational corporations",
author = "Renate Kratochvil and Nell, {Phillip Christopher}",
note = "CASE - Reference no. 9B19M077",
year = "2019",
language = "English",
publisher = "Ivey Publishing",
type = "Other",

}

Pfizer and the Challenges of the Global Pharmaceutical Industry 2019 - B. / Kratochvil, Renate; Nell, Phillip Christopher.

17 p. Ontario : Ivey Publishing. 2019, Case.

Research output: Other contributionEducation

TY - GEN

T1 - Pfizer and the Challenges of the Global Pharmaceutical Industry 2019 - B

AU - Kratochvil, Renate

AU - Nell, Phillip Christopher

N1 - CASE - Reference no. 9B19M077

PY - 2019

Y1 - 2019

N2 - Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.Learning Objective:After working through the assignment questions for Case B, students will be able to do the following:Analyze how pharmaceutical companies strategically respond to changes in the industry.Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.Identify, analyze, and evaluate relevant data and information.

AB - Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.Learning Objective:After working through the assignment questions for Case B, students will be able to do the following:Analyze how pharmaceutical companies strategically respond to changes in the industry.Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.Identify, analyze, and evaluate relevant data and information.

KW - Industry analysis

KW - Structured analysis

KW - Data management

KW - Multinational corporations

KW - Industry analysis

KW - Structured analysis

KW - Data management

KW - Multinational corporations

M3 - Other contribution

PB - Ivey Publishing

CY - Ontario

ER -